On April 12, 2024, Daniel Donovan resigned from the Audit Committee of the Board of Directors of Intensity Therapeutics, Inc. prior to the Company entering into a non-material transaction with a service organization controlled by Mr. Donovan. Mr. Donovan remains on the Board and a member of the Board?s Compensation Committee and Nominating and Corporate Governance Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5 USD | +3.31% | +3.52% | -41.66% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.66% | 66.35M | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- INTS Stock
- News Intensity Therapeutics, Inc.
- Intensity Therapeutics, Inc. Announces Resignation of Daniel Donovan from Audit Committee of the Board of Directors